Tilray, Inc. (TLRY) Misses Q1 EPS by $1.31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Tilray, Inc. Reports First Quarter 2020 Financial Results
May 11, 2020 4:05 PM EDTQuarterly Revenue Increased 126% to $52.1 Million (C$70.7 Million) Compared to the First Quarter of 2019 and 11% Sequentially from the Fourth Quarter of 2019
International Medical Cannabis Sales Exceeded Canada Medical Sales by 43% in the Quarter
Implemented Cost Reductions Designed to Achieve Approximately $40 Million Annualized Savings
Reduced Net Loss by $35 Million, or 16%, Compared to the Fourth Quarter of 2019
Implemented COVID-19 Related Protocols to Ensure the Health of Our Global Workforce and Satisfy Patient and Consumer Needs
Focused on Achieving Positive Adjusted EBITDA by End of the Fourth Quarter of 2020
NANAIMO, British... More
